Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use (Q83644767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Jacobus Burggraaf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mandana Rad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Cornelis Kluft

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Piet Meijer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Marieke L. de Kam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21417560

27 November 2024

Adam F. Cohen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21417560

27 November 2024

Gary S. Grubb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21417560

27 November 2024

Ginger D. Constantine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21417560

27 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21417560

27 November 2024

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

April 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21417560

full work available at URL

27 November 2024

http://www.tandfonline.com/doi/pdf/10.3109/13625187.2011.556761

1 reference

Crossref

DOI

https://api.crossref.org/works/10.3109/13625187.2011.556761

The European Journal of Contraception Reproductive Health Care

27 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

85-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg).

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Lipid metabolism effects with desogestrel-containing oral contraceptives

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).

27 November 2024

1 reference

https://api.crossref.org/works/10.3109/13625187.2011.556761

27 November 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417560%20AND%20SRC:MED&resulttype=core&format=json